Rate My Professor Lei Jin

Lei Jin is an NHMRC Investigator Fellow in the School of Medicine and Public Health at the University of Newcastle, Australia. He also holds a Cancer Institute NSW Career Development Fellowship. His research specializes in cancer biology, focusing on cell signaling, apoptosis, signal transduction, microRNAs, non-coding RNAs, and RNA therapeutics, with particular attention to melanoma and other cancers. Jin's work explores mechanisms of tumor progression, therapy resistance, and potential therapeutic targets. He has contributed to discoveries such as the oncogenic role of RIP1 kinase in melanoma and the functions of long non-coding RNAs in regulating cancer processes.

Jin's career includes postdoctoral positions at the Kolling Institute of Medical Research, University of Sydney, and Royal North Shore Hospital from June 2011 to February 2013, followed by roles at the University of Newcastle, including a Cancer Institute NSW Early Career Fellowship from 2014 to 2017. He has received major funding, including NHMRC Project Grants over $400,000 in 2015, an NHMRC Investigator Grant of $1,399,339 in 2019, and participation in $1.5 million cancer research grants. Affiliated with the Hunter Medical Research Institute Cancer research program, Jin has authored over 110 publications with more than 8,400 citations. Key publications include 'The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis' (Nature Communications, 2021), 'The pan-cancer lncRNA MILIP links c-Myc to p53 repression' (2020), 'The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis' (Molecular Cell, 2022), and 'RIP1 kinase is an oncogenic driver in melanoma' (Cancer Research, 2015). His research impacts the understanding of cancer cell survival and offers insights into novel treatments.